history of concurrent psychiatric illness that would preclude compliance with the protocol and ability to complete the study safely
active suicidal or homicidal ideation
variable psychiatric symptoms such as rapid cycling or severe premenstrual syndrome that could interfere with accurate assessment of the treatment effect
history of substance abuse/dependence with less than one year remission
GAF < 50
light treatment in the previous month
previous failure to respond significantly to an adequate course of light treatment
pregnant or lactating
any antidepressant or mood-stabilizing medications or remedies (even if taken for non-psychiatric indications), including selective serotonin-reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, antipsychotics, lithium, benzodiazepines, monoamine oxidase inhibitors, tryptophan, St. John’s wort
nightwork or other habitual alteration of sleep/wake cycle
medical conditions that affect mood or produce hallmark symptoms of mood disorder
use of photosensitizing medications (amiodarone, benoxaprofen, chlorpromazine, demeclocycline, fleroxacin, nalidixic acid, ofloxacin, piroxicam, porfimer, psoralens, quinidine, temoporfin) or remedies (St. John’s wort, melatonin)
macular degeneration or cataract of a level that would significantly affect transmission or processing of light through either eye (LOCS3 # 4)
history of eye trauma and/or use of medication such as tetracycline or oral isoretinoin (Accutane), that would affect the safety of light exposure treatment or complaints of eyestrain or abnormal tearing with computer use of up to 30 min at a time